Bi/tri-specific antibodies (HN-Fc-CD16 and HN-Fc-IL-15-CD16) cross-linking natural killer (NK)-CD16 and Newcastle Disease Virus (NDV)-HN, enhanced NK activation for cancer immunotherapy.
Int Immunopharmacol
; 96: 107762, 2021 Jul.
Article
in En
| MEDLINE
| ID: mdl-34162140
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Newcastle disease virus
/
HN Protein
/
Receptors, IgG
/
Antibodies, Bispecific
/
Antineoplastic Agents, Immunological
/
Neoplasms
Type of study:
Prognostic_studies
Limits:
Humans
Language:
En
Journal:
Int Immunopharmacol
Journal subject:
ALERGIA E IMUNOLOGIA
/
FARMACOLOGIA
Year:
2021
Document type:
Article
Country of publication:
Países Bajos